Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01161667 · ClinicalTrials.gov registry record · NA
Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions
A NA study, sponsored by Roxane Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01161667: Completed NA study, sponsored by Roxane Laboratories.
NCT01161667 is a NA study that has completed, run by Roxane Laboratories. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01161667, a NA study, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The objective of this study was to prove the bioequivalence of Naratriptan Hydrochloride Tablet under fasted conditions.
Interventions
- DRUG naratriptan hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-09 |
| Est. Completion | 2007-09 |
| Phase | NA |
What the finished NCT01161667 record still lists
NCT01161667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which naratriptan hydrochloride is the first listed.
NCT01161667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01161667 about?
NCT01161667 is a clinical study titled "Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions". The objective of this study was to prove the bioequivalence of Naratriptan Hydrochloride Tablet under fasted conditions.
What is the current status of trial NCT01161667?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2007-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT01161667?
The interventions under investigation include: naratriptan hydrochloride (DRUG).
Who is sponsoring clinical trial NCT01161667?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01161667's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia